Sóskuti, E.; Szilvásy, N.; Temesszentandrási-Ambrus, C.; Urbán, Z.; CsÃkvári, O.; Szabó, Z.; Kecskeméti, G.; Pusztai, É.; Gáborik, Z.
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction. Pharmaceutics 2024, 16, 736.
https://doi.org/10.3390/pharmaceutics16060736
AMA Style
Sóskuti E, Szilvásy N, Temesszentandrási-Ambrus C, Urbán Z, CsÃkvári O, Szabó Z, Kecskeméti G, Pusztai É, Gáborik Z.
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction. Pharmaceutics. 2024; 16(6):736.
https://doi.org/10.3390/pharmaceutics16060736
Chicago/Turabian Style
Sóskuti, EmÅ‘ke, Nóra Szilvásy, Csilla Temesszentandrási-Ambrus, Zoltán Urbán, Olivér CsÃkvári, Zoltán Szabó, Gábor Kecskeméti, Éva Pusztai, and Zsuzsanna Gáborik.
2024. "Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction" Pharmaceutics 16, no. 6: 736.
https://doi.org/10.3390/pharmaceutics16060736
APA Style
Sóskuti, E., Szilvásy, N., Temesszentandrási-Ambrus, C., Urbán, Z., CsÃkvári, O., Szabó, Z., Kecskeméti, G., Pusztai, É., & Gáborik, Z.
(2024). Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction. Pharmaceutics, 16(6), 736.
https://doi.org/10.3390/pharmaceutics16060736